PUBLISHER: TechSci Research | PRODUCT CODE: 1668147
PUBLISHER: TechSci Research | PRODUCT CODE: 1668147
We offer 8 hour analyst time for an additional research. Please contact us for the details.
Global Veterinary Biomarkers Market was valued at USD 965.53 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.30% through 2030. The Global Veterinary Biomarkers Market refers to the sector within the veterinary healthcare industry that deals with the use of biomarkers for diagnosing diseases, monitoring animal health, and assessing treatment efficacy in animals. Biomarkers are measurable indicators, such as proteins, genes, or metabolites, that can be used to detect and quantify various physiological and pathological processes in animals.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 965.53 Million |
Market Size 2030 | USD 1940.86 Million |
CAGR 2025-2030 | 12.30% |
Fastest Growing Segment | Companion Animals |
Largest Market | North America |
Key Market Drivers
Rising Prevalence of Animal Diseases and Zoonotic Infections
The rising prevalence of animal diseases and zoonotic infections is a critical factor driving the growth of the Global Medical Scheduling Software Market. Globally, zoonotic diseases account for approximately one billion illness cases and millions of fatalities annually. Zoonoses comprise 60% of all newly emerging infectious diseases, underscoring their significant public health impact. Over the past 30 years, more than 30 novel human pathogens have been identified, with 75% originating from animals, highlighting the critical need for enhanced disease surveillance, veterinary healthcare advancements, and cross-sectoral collaboration to mitigate the risks of animal-to-human transmission. As veterinary clinics, hospitals, research centers, and government agencies strive to manage the increasing burden of infectious and chronic diseases in animals, the demand for efficient appointment scheduling, resource allocation, and workflow optimization is escalating. Below is an in-depth analysis of how the growing incidence of animal-related diseases is fueling the expansion of medical scheduling software in the veterinary and broader healthcare sectors.
Key Market Challenges
Validation and Standardization
Validating and standardizing biomarker assays for veterinary use is essential for ensuring accuracy and reliability. Establishing consistent standards and methodologies is challenging due to the diversity of animal species, breeds, and health conditions. This lack of standardization can hinder the widespread adoption of biomarker-based diagnostics and treatments.
Key Market Trends
Rise of Point-of-Care Diagnostics
Point-of-care diagnostics are revolutionizing veterinary medicine by providing rapid and on-site testing capabilities. These portable and user-friendly devices allow veterinarians to perform biomarker-based tests right in the clinic, enabling quicker diagnoses and immediate treatment decisions. The convenience of point-of-care testing is expected to drive its adoption in veterinary practices.
In this report, the Global Veterinary Biomarkers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Biomarkers Market.
Global Veterinary Biomarkers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: